Chad Winters West Pharmaceutical Services Inc (WST) insider trading activity

Chad Winters is VP, Chief Accounting Officer of WEST PHARMACEUTICAL SERVICES INC. Currently has a direct ownership of 1,363 shares of WST, which is worth approximately $314,239. The most recent transaction as insider was on Feb 18, 2025, when has been sold 27 shares (Common Stock) at a price of $211.0 per share, resulting in proceeds of $5,697. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.36K

4.2% 3M change

5.87% 12M change

Total Value Held $314,239

Chad Winters Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2025	SELL Payment of exercise price or tax liability	$5,697 $211.0 p/Share	27 Reduced 1.94%	1,363 Common Stock
Feb 18 2025	BUY Exercise of conversion of derivative security	$17,302 $211.0 p/Share	82 Added 5.57%	1,390 Common Stock
Mar 11 2024	SELL Open market or private sale	$292,438 $358.82 p/Share	815 Reduced 38.39%	1,308 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	$116,923 $173.22 p/Share	675 Added 24.12%	2,123 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	179 Added 11.0%	1,448 Common Stock
Dec 01 2023	SELL Open market or private sale	$353,537 $349.0 p/Share	1,013 Reduced 44.39%	1,269 Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	$126,181 $158.32 p/Share	797 Added 25.89%	2,282 Common Stock
May 30 2023	SELL Exercise of conversion of derivative security	$296,052 $339.51 p/Share	872 Reduced 37.59%	1,448 Common Stock
May 30 2023	BUY Exercise of conversion of derivative security	$125,070 $143.43 p/Share	872 Added 27.32%	2,320 Common Stock
May 05 2023	SELL Payment of exercise price or tax liability	$3,684 $368.46 p/Share	10 Reduced 0.69%	1,448 Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	$145,979 $306.68 p/Share	476 Added 24.61%	1,458 Common Stock
Oct 31 2022	SELL Payment of exercise price or tax liability	$10,598 $225.51 p/Share	47 Reduced 4.57%	982 Common Stock
May 05 2022	SELL Payment of exercise price or tax liability	$3,148 $314.76 p/Share	10 Reduced 0.93%	1,062 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	$152,820 $369.13 p/Share	414 Added 27.86%	1,072 Common Stock
Oct 29 2021	SELL Payment of exercise price or tax liability	$20,204 $429.88 p/Share	47 Reduced 6.67%	658 Common Stock
May 05 2021	SELL Payment of exercise price or tax liability	$3,286 $328.6 p/Share	10 Reduced 1.4%	705 Common Stock
Mar 12 2021	BUY Grant, award, or other acquisition	$44,475 $261.62 p/Share	170 Added 19.23%	714 Common Stock
Oct 29 2020	SELL Payment of exercise price or tax liability	$12,936 $275.23 p/Share	47 Reduced 7.95%	544 Common Stock

Chad Winters

VP, Chief Accounting Officer

Exton, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WST shares.

Notify only if

Value

Insider Trading

Get notified when an West Pharmaceutical Services Inc insider buys or sells WST shares.

Notify only if

Operation

Value

Type

News

Receive news related to WEST PHARMACEUTICAL SERVICES INC

Track Activities on WST

Account